Clinical trial
Long Term Treatment With Galantamine In Dementia
NCT00216502 is registered in ClinicalTrials.gov with Janssen-Cilag S.p.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long Term Treatment With Galantamine In Dementia
- Lead sponsor
- Janssen-Cilag S.p.A.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 31, 2001
- Completion date
- November 30, 2005
- Enrollment
- 254 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.